Liberation Labs Secures $30 Million in Equipment Funding for First Biomanufacturing Facility
12 avr. 2023 07h00 HE
|
Liberation Labs
RICHMOND, Ind., April 12, 2023 (GLOBE NEWSWIRE) -- Liberation Labs, industrial biotech’s fabrication partner, has secured $30 million in equipment financing to advance development of its first...
Dyadic to Present at World Vaccine Congress Washington 2023
30 mars 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Dyadic Reports 2022 Year End Results and Recent Company Progress
29 mars 2023 16h00 HE
|
Dyadic International, Inc.
Received regulatory approval for the ongoing First-In-Human Phase 1 trial to demonstrate clinical safety and antibody response in humans for DYAI-100 COVID-19 recombinant protein receptor binding...
Dyadic to Report 2022 Year End Financial Results on Wednesday, March 29, 2023
15 mars 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 15, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing
11 mars 2023 07h00 HE
|
Cytovance Biologics
OKLAHOMA CITY, March 11, 2023 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance Biologics), a biopharmaceutical contract development and manufacturing organization (CDMO), and Phenotypeca...
BioP2P Network Names Scientific Advisory Board to Guide Efforts to Fuel Growing U.S. Bioeconomy
08 mars 2023 05h15 HE
|
California Biomanufacturing Center
VACAVILLE, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- The BioProcess to Product (BIOP2P) Network, a national program to accelerate the transformation of manufacturing in the United States for the...
Dyadic to Present at Roth Investor Conference and Upcoming Industry Events
01 mars 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Green Bioactives engages biomanufacturing expert John Stevenson to lead production scale-up
21 févr. 2023 02h30 HE
|
Green Bioactives Limited
Edinburgh, Scotland, 21 February 2023 – Green Bioactives Limited (‘GBL’), a world-leader in the discovery, development and sustainable production of high-value natural products derived from plant cell...
Dyadic to Participate in Two Upcoming Investor Conferences
02 févr. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Premiere Synthetic Biology Event on Track for Record Attendance - 2023
01 févr. 2023 14h36 HE
|
SynBioBeta
SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO, Feb. 01, 2023 (GLOBE NEWSWIRE) --...